Literature DB >> 6971296

Variants of 3T3 cells lacking mitogenic response to the tumor promoter tetradecanoyl-phorbol-acetate.

E Butler-Gralla, H R Herschman.   

Abstract

The potent tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) can stimulate quiescent, nonproliferating 3T3 cells to reenter the cell cycle and divide. We have previously used a selection technique developed in our laboratory to isolate variant cell lines which no longer divide in response to epidermal growth factor. We have now utilized the same selection procedure to isolate, from 3T3 cells, two variant cell lines, TNR-2 and TNR-9, which retain growth control and divide in response to elevated serum or fibroblast growth factor, but which do not respond to TPA. The variants do not incorporate precursors into DNA in response to TPA, demonstrating that the cells do not enter the S phase of the cell cycle. The TPA nonresponsive variant TNR-2 cannot respond to epidermal growth factor; TNR-9 responds to this mitogen. TNR-2 variant cells, which do not respond to EGF, do not bind 125I-EGF. TPA can modulate 125I-EGF binding to TNR-9 cells in a manner similar to its action on parental 3T3 cells. This TPA-induced alteration of EGF binding indicates that TNR-9 cells still interact with TPA, despite their inability to mount a mitogenic response.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971296     DOI: 10.1002/jcp.1041070108

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  Epidermal growth factor-nonresponsive 3T3 variants do not contain epidermal growth factor receptor-related antigens or mRNA.

Authors:  C A Schneider; R W Lim; E Terwilliger; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

2.  Protein phosphorylation in a tetradecanoyl phorbol acetate-nonproliferative variant of 3T3 cells.

Authors:  R Bishop; R Martinez; M J Weber; P J Blackshear; S Beatty; R Lim; H R Herschman
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

3.  Abnormal protein kinase C down regulation and reduced substrate levels in non-phorbol ester-responsive 3T3-TNR9 cells.

Authors:  H P Biemann; R L Erikson
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

4.  A Swiss 3T3 variant cell line resistant to the effects of tumor promoters cannot be transformed by src.

Authors:  M Nori; L K Shawver; M J Weber
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

5.  Fibroblast growth factor induces the soft agar growth of two non-transformed cell lines.

Authors:  A Rizzino; E Ruff
Journal:  In Vitro Cell Dev Biol       Date:  1986-12

6.  Induction of tumor promotor-inducible genes in murine 3T3 cell lines and tetradecanoyl phorbol acetate-nonproliferative 3T3 variants can occur through protein kinase C-dependent and -independent pathways.

Authors:  R W Lim; B C Varnum; T G O'Brien; H R Herschman
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

7.  Regulation of tetradecanoyl phorbol acetate-induced responses in NIH 3T3 cells by GAP, the GTPase-activating protein associated with p21c-ras.

Authors:  M Nori; G L'Allemain; M J Weber
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Endothelin rapidly stimulates mitogen-activated protein kinase activity in rat mesangial cells.

Authors:  Y Wang; M S Simonson; J Pouysségur; M J Dunn
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

9.  A 12-O-tetradecanoylphorbol-13-acetate (TPA)-nonproliferative variant of 3T3 cells is resistant to TPA-enhanced gene amplification.

Authors:  H R Herschman
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

10.  Defective regulation of mitogen-activated protein kinase activity in a 3T3 cell variant mitogenically nonresponsive to tetradecanoyl phorbol acetate.

Authors:  G L'Allemain; T W Sturgill; M J Weber
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.